HCV Genotype 3 and HIVHCV Coinfection Whats So Special About HCVGT3 Infection Why Talk About HIVHCV Coinfection ALLY3 Study ALLY3 cont Daclatasvir Sofosbuvir for 12 Weeks ALLY3 Study ID: 715409
Download Presentation The PPT/PDF document "Advances in the Treatment of" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Advances in the Treatment of HCV Genotype 3 and HIV/HCV Coinfection Slide2Slide3Slide4Slide5
What's So "Special" About HCV-GT3 Infection?Slide6
Why Talk About HIV/HCV Coinfection?Slide7
ALLY-3 StudySlide8
ALLY-3 (cont)Daclatasvir + Sofosbuvir for 12 WeeksSlide9
ALLY-3+ StudyDaclatasvir + Sofosbuvir + Ribavirin for 12 or 16 Weeks in Patients With Advanced Fibrosis or Cirrhosis Infected With HCV-GT3Slide10
ALLY-3+ Study (cont) Slide11
ALLY-3+ Study, contSlide12
ASTRAL-3 StudySofosbuvir/VelpatasvirSlide13
ASTRAL-3 Study (cont)Slide14
ASTRAL-3 Study (cont)Slide15
Real-World DataHow Effective and Safe Are These Regimens in Clinical Practice?Slide16
French Multicenter Compassionate Use Program Interim AnalysisSlide17
French Multicenter Compassionate Use Program Interim Analysis (cont)Slide18
European Multicenter Compassionate Use ProgramInterim AnalysisSlide19
Back to the Ribavirin QuestionSlide20
ALLY-2Daclatasvir/SofosbuvirSlide21
Rethinking HIV/HCV CoinfectionAre the Results Really As Good As for HCV Monoinfection?Slide22
GECCO: Real-World DataSofosbuvir/Ledipasvir for 8 WeeksSlide23
Sofosbuvir/Daclatasvir In Patients With HIV/HCV Coinfection and Advanced Liver DiseaseA Real-World TrialSlide24
C-EDGEGrazoprevir/Elbasvir for 12 Weeks in HCV-GT1, 4, 6Slide25
C-EDGE, contEvaluated Outcomes In Monoinfection and CoinfectionSlide26
C-EDGE, contGrazoprevir/Elbasvir for 12 Weeks in HCV-GT1, 4, 6Slide27
SummarySlide28
AbbreviationsSlide29
Abbreviations (cont)